Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls

NCT ID: NCT01490944

Last Updated: 2012-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

360 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a clinical trial to assess the effectiveness of Vitamin B12 supplementation along with Iron Folic Acid (IFA) in combating anaemia. Adolescent anaemic girls will be randomly divided into two groups.

* Group 1: IFA weekly supplementation along with Information, Education, Communication sessions
* Group 2: IFA + Cyanocobalamin weekly supplementation along with Information, Education, Communication sessions

Duration of supplementation: 6 months

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a randomized clinical trial to be conducted on mild or moderately anaemic adolescent girls (11-18 yrs) in a slum in Delhi. Anaemic adolescent girls (n=360) will be randomly divided into two groups. Group 1(n=180) will be given weekly supplementation of Iron (100 mg) and Folic acid (500 mcg) for six months, whereas group 2 (n=180) will be given weekly supplementation of Iron Folic Acid and cyanocobalamin (Vitamin B12) to assess the impact of Vitamin B12 supplementation on reducing the prevalence of anaemia. For first six weeks, 500 mcg/ week of cyanocobalamin will be given , followed by maintenance dose of 15 mcg/ week for rest of 20 weeks.

Anthropometric measurements and dietary information will be collected besides biochemical analysis. IEC sessions will be organized for both the groups.The study hypothesis is that Vitamin B12 supplementation along with iron folic acid (IFA) is more effective in reducing the prevalence of anaemia as compared to IFA supplementation alone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anaemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Iron and Folic Acid

Group Type ACTIVE_COMPARATOR

Iron and Folic Acid

Intervention Type DRUG

Iron= 100 mg, Folic acid= 500 mcg weekly supplementation in the form of capsule for 6 months

Iron, Folic acid and cyanocobalamin

Group Type EXPERIMENTAL

Iron, Folic acid and Cyanocobalamin

Intervention Type DRUG

Total duration= 6 months Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 500 mcg weekly supplementation in the form of capsule for 6 weeks

Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 15 mcg weekly supplementation in the form of capsule for next 20 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Iron, Folic acid and Cyanocobalamin

Total duration= 6 months Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 500 mcg weekly supplementation in the form of capsule for 6 weeks

Iron=100 mg, Folic acid= 500 mcg, Cyanocobalamin 15 mcg weekly supplementation in the form of capsule for next 20 weeks

Intervention Type DRUG

Iron and Folic Acid

Iron= 100 mg, Folic acid= 500 mcg weekly supplementation in the form of capsule for 6 months

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willingness to participate
* Unmarried or married (who still reside with their parents, i.e. prior to 'Gauna') adolescent girl.

Exclusion Criteria

* Severe anaemia
* Pregnant Adolescent girls
* Medical conditions like TB, Cancer etc
Minimum Eligible Age

11 Years

Maximum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Delhi University

OTHER

Sponsor Role collaborator

Indian Council of Medical Research

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

G.S.Toteja

Scientist-F (Deputy Director General, Senior Grade) and Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr. Gurdayal S Toteja, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Indian Council of Medical Research

Priyanka Gupta, M.Sc

Role: PRINCIPAL_INVESTIGATOR

Indian Council of Medical Research

Dr. Neena Bhatia, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Delhi University

Dr. Naval K Vikram, M.D.

Role: PRINCIPAL_INVESTIGATOR

All India Institute of Medical Sciences

Dr. Anupa Siddhu, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Delhi University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kirti Nagar Slums

New Delhi, National Capital Territory of Delhi, India

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

India

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dr. Gurdayal S Toteja, Ph.D

Role: CONTACT

Phone: +91-11-23731633

Email: [email protected]

Priyanka Gupta, M.Sc

Role: CONTACT

Phone: +91-11-26890602

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gurdayal S Toteja, Ph.D

Role: primary

Priyanka Gupta, M.Sc

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Basu RN, Sood SK, Ramachandran K, Mathur M, Ramalingaswami V. Etiopathogenesis of nutritional anemia in pregnancy: a therapeutic approach. Am J Clin Nutr. 1973 Jun;26(6):591-4. doi: 10.1093/ajcn/26.6.591. No abstract available.

Reference Type BACKGROUND
PMID: 4575153 (View on PubMed)

Sood SK, Ramachandran K, Mathur M, Gupta K, Ramalingaswamy V, Swarnabai C, Ponniah J, Mathan VI, Baker SJ. W.H.O. sponsored collaborative studies on nutritional anaemia in India. 1. The effects of supplemental oral iron administration to pregnant women. Q J Med. 1975 Apr;44(174):241-58.

Reference Type BACKGROUND
PMID: 1103213 (View on PubMed)

Gomber S, Agarwal KN, Mahajan C, Agarwal N. Impact of daily versus weekly hematinic supplementation on anemia in pregnant women. Indian Pediatr. 2002 Apr;39(4):339-46.

Reference Type BACKGROUND
PMID: 11976463 (View on PubMed)

Kotecha PV, Nirupam S, Karkar PD. Adolescent girls' Anaemia Control Programme, Gujarat, India. Indian J Med Res. 2009 Nov;130(5):584-9.

Reference Type BACKGROUND
PMID: 20090111 (View on PubMed)

Agarwal KN, Gomber S, Bisht H, Som M. Anemia prophylaxis in adolescent school girls by weekly or daily iron-folate supplementation. Indian Pediatr. 2003 Apr;40(4):296-301.

Reference Type BACKGROUND
PMID: 12736400 (View on PubMed)

Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996 Oct 12;348(9033):992-6. doi: 10.1016/S0140-6736(96)02341-0.

Reference Type BACKGROUND
PMID: 8855856 (View on PubMed)

Ahmed F, Khan MR, Akhtaruzzaman M, Karim R, Marks GC, Banu CP, Nahar B, Williams G. Efficacy of twice-weekly multiple micronutrient supplementation for improving the hemoglobin and micronutrient status of anemic adolescent schoolgirls in Bangladesh. Am J Clin Nutr. 2005 Oct;82(4):829-35. doi: 10.1093/ajcn/82.4.829.

Reference Type BACKGROUND
PMID: 16210713 (View on PubMed)

Deshmukh PR, Garg BS, Bharambe MS. Effectiveness of weekly supplementation of iron to control anaemia among adolescent girls of Nashik, Maharashtra, India. J Health Popul Nutr. 2008 Mar;26(1):74-8.

Reference Type BACKGROUND
PMID: 18637530 (View on PubMed)

Sen A, Kanani SJ. Impact of iron-folic acid supplementation on cognitive abilities of school girls in Vadodara. Indian Pediatr. 2009 Feb;46(2):137-43.

Reference Type BACKGROUND
PMID: 19242031 (View on PubMed)

Shobha S, Sharada D. Efficacy of twice weekly iron supplementation in anemic adolescent girls. Indian Pediatr. 2003 Dec;40(12):1186-90.

Reference Type BACKGROUND
PMID: 14722370 (View on PubMed)

Singla PN, Bhardwaj B, Agarwal DK, Agarwal KN. Vitamin B12 and folic acid in preschool anemia. Indian Pediatr. 1985 Jan;22(1):27-33. No abstract available.

Reference Type BACKGROUND
PMID: 4077257 (View on PubMed)

Singla PN, Gupta HP, Ahuja C, Agarwal KN. Deficiency anaemias in preschool children--estimation of prevalence based on response to haematinic supplementation. J Trop Pediatr. 1982 Apr;28(2):77-80. doi: 10.1093/tropej/28.2.77. No abstract available.

Reference Type BACKGROUND
PMID: 6763946 (View on PubMed)

Mozaffari-Khosravi H, Noori-Shadkam M, Fatehi F, Naghiaee Y. Once weekly low-dose iron supplementation effectively improved iron status in adolescent girls. Biol Trace Elem Res. 2010 Jun;135(1-3):22-30. doi: 10.1007/s12011-009-8480-0. Epub 2009 Aug 4.

Reference Type BACKGROUND
PMID: 19652922 (View on PubMed)

Hettiarachchi M, Liyanage C, Wickremasinghe R, Hilmers DC, Abrams SA. The efficacy of micronutrient supplementation in reducing the prevalence of anaemia and deficiencies of zinc and iron among adolescents in Sri Lanka. Eur J Clin Nutr. 2008 Jul;62(7):856-65. doi: 10.1038/sj.ejcn.1602791. Epub 2007 May 16.

Reference Type BACKGROUND
PMID: 17522609 (View on PubMed)

Worthington-White DA, Behnke M, Gross S. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity. Am J Clin Nutr. 1994 Dec;60(6):930-5. doi: 10.1093/ajcn/60.6.930.

Reference Type BACKGROUND
PMID: 7985636 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3/1/2/34/10-RHN

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CNRT/Ph.D/4/2010

Identifier Type: -

Identifier Source: org_study_id